about
CNS Remyelination and the Innate Immune SystemThe Role of Astrocytes in Multiple Sclerosis ProgressionAdrenergic regulation of innate immunity: a reviewLithium controls central nervous system autoimmunity through modulation of IFN-γ signalingPrecision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive AstrocytesMultiple Sclerosis and T Lymphocytes: An Entangled StoryThe detection of surfactant proteins A, B, C and D in the human brain and their regulation in cerebral infarction, autoimmune conditions and infections of the CNS.Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation.Association of plasma levels of Protein S with disease severity in multiple sclerosis.Soluble CD163 as a marker of macrophage activity in newly diagnosed patients with multiple sclerosis.Allopregnanolone and neuroinflammation: a focus on multiple sclerosis.Thrombotic processes in multiple sclerosis as manifestation of innate immune activation.Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease?Involvement of the janus kinase/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis.Role of CCR2 in inflammatory conditions of the central nervous system.Abundant kif21b is associated with accelerated progression in neurodegenerative diseases.The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation.Interleukin-22 is increased in multiple sclerosis patients and targets astrocytesIL-10-dependent Tr1 cells attenuate astrocyte activation and ameliorate chronic central nervous system inflammationNK cell autoreactivity and autoimmune diseases.Opportunities for Translation from the Bench: Therapeutic Intervention of the JAK/STAT Pathway in Neuroinflammatory Diseases.Innate immune responses in the CNS: role of toll-like receptors, mechanisms, and therapeutic opportunities in multiple sclerosis.The role of sphingosine 1-phosphate in immunity and sepsis.Multiple sclerosis: Prospects and promise.Immune responses to non-tumor antigens in the central nervous system.Brain-peripheral cell crosstalk in white matter damage and repair.Microvesicles: What is the Role in Multiple Sclerosis?Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive CannabinoidRole of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.Dopaminergic Regulation of Innate Immunity: a Review.IL-17 induces MIP-1α expression in primary mouse astrocytes via TRPC channel.Natural killer cell subsets in cerebrospinal fluid of patients with multiple sclerosis.Astrocytic tight junctions control inflammatory CNS lesion pathogenesis.CXCR3 modulates glial accumulation and activation in cuprizone-induced demyelination of the central nervous system.Functional DNA methylation in a transcript specific 3'UTR region of TrkB associates with suicide.Methylmalonate Induces Inflammatory and Apoptotic Potential: A Link to Glial Activation and Neurological Dysfunction.Severe oxidative stress in an acute inflammatory demyelinating model in the rhesus monkey.Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis.Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.
P2860
Q26747242-B2210BD5-EE5D-4DC8-9A31-A96FB4D41B2DQ26782843-40F4504C-B018-4482-91DE-063DC1DAFC68Q26796227-6EC86636-1CB3-4AB9-A68E-2DC5564432E6Q27324211-7D93355C-54FE-4EE3-9D32-9C3F374002CDQ28078621-8F6710D2-4420-4767-9AC1-9AA03A74D8DEQ28086853-749997AC-D2AE-48D6-AB22-DD7811B724C5Q30317702-B4BDC15B-1411-4689-BC3E-CC666414B949Q30849102-33DA4392-E7D2-4FD1-9FAD-433B35E7468FQ33692556-58A81D48-93A6-4FB4-86C1-D075CDA19EF0Q33700473-CE07B8CA-F47D-43AD-9B1E-6BF08E5183D5Q33701762-25B95F73-CDFC-4CCE-92DD-BA8B09A191BDQ33851359-FEC50B4F-845C-4F54-A807-8F41ACD31576Q33911142-819DA751-6DAE-42DF-9DAC-3ABA7E827671Q33988247-BD2CE5BA-BBAB-4D5E-8093-BDEEEF102D2CQ34153471-B67C5EA5-E0D6-4C24-B689-FFA1F694FD46Q34392911-46CFF9D8-5A66-45C7-9A94-7EA7014921AAQ34468304-5CA5D444-539D-42EF-9CD2-2443B89727CDQ34632490-8FD6B347-5406-4426-900C-2E8A9937C4B6Q35780751-33E5DDD1-FB1B-40B8-9B67-D6D6891E217FQ37081950-25104A02-6F26-44CA-BE61-0BECA6B47F02Q37552129-468DB73C-8972-4531-AD0E-771239936614Q37670027-72A9F679-A63D-4623-8F0A-23A7B73C7534Q38118170-0FEC7F85-15B3-435D-A144-561A376C0720Q38124035-614A6E78-9D3F-4927-B6EF-3DF5FC27F77DQ38129775-CDAAC0A3-7FB2-4D20-9DFD-A21E30A3A361Q38272285-67357BA6-585D-46C2-B36A-CAED16540252Q38414220-D2665F90-9A94-4A19-8622-E200812C8C27Q38527788-6B0412E2-F9E5-4B08-B2F7-C82B90E78BCDQ38634379-E0E70696-1142-471D-9023-F2204B82041DQ39057292-C1AB9B9A-E987-4086-B9E3-010DCA079E5DQ39348712-64D8448A-329A-44B2-A47F-ED2CC8F6F6BCQ40091331-81081DE9-BFEE-46E1-9B5D-8D6976B486BEQ41615056-24472064-0381-42C2-8211-03E53126D408Q42644144-7CA1AB9C-915C-49B4-BCB8-855380A4925EQ42734636-4BEF974A-B410-4EBF-BB92-5A13B4A99576Q42877964-321D6897-2442-4019-92FF-2B0F6EDBF343Q46386748-B405DDDB-4FA5-491A-B6F6-1B678F08FEBAQ47095705-DE4A978A-20E4-42B6-BCB0-33EDECE721EDQ47552983-626DE301-B70D-4186-8306-2A6D4A31F6E6Q47758851-0C50CFF6-90BB-40B0-A5F7-EE13FE352A15
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The innate immune system in demyelinating disease
@ast
The innate immune system in demyelinating disease
@en
The innate immune system in demyelinating disease
@nl
type
label
The innate immune system in demyelinating disease
@ast
The innate immune system in demyelinating disease
@en
The innate immune system in demyelinating disease
@nl
prefLabel
The innate immune system in demyelinating disease
@ast
The innate immune system in demyelinating disease
@en
The innate immune system in demyelinating disease
@nl
P2860
P3181
P1476
The innate immune system in demyelinating disease
@en
P2093
Francisco J Quintana
P2860
P304
P3181
P356
10.1111/J.1600-065X.2012.01135.X
P407
P577
2012-07-01T00:00:00Z